FDA's GENERIC DRUGS ADVISORY COMMITTEE LIKELY TO GAIN FOUR PHARMACISTS; CDER's 17 ADVISORY COMMITTEES LOOKING FOR MEMBERS TO FILL 25 VACANT SLOTS
Executive Summary
FDA's Generics Drugs Advisory Committee in on the verge of adding four pharmacists as new members following efforts by the American Pharmaceutical Association, the American Society of Hospital Pharmacists, the American College of Clinical Pharmacy and the American Association of Colleges of Pharmacy to nominate qualified pharmacists to FDA advisory committees.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth